Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease
Identifieur interne : 004548 ( Main/Curation ); précédent : 004547; suivant : 004549Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease
Auteurs : John L. Goudreau [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Andrew B. Singleton [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2002-11.
Descripteurs français
- Pascal (Inist)
- Wicri :
English descriptors
- KwdEn :
- Adult, Age Factors, Aged, Aged, 80 and over, Amine oxidase (flavin-containing), Biological transport, COMT, Case control study, Case-Control Studies, Catechol O-Methyltransferase (genetics), Catechol O-methyltransferase, DAT1, Dopamine, Dopamine Plasma Membrane Transport Proteins, Exploration, Female, Genetics, Genotype, Human, Humans, Likelihood Functions, MAO‐B, Male, Membrane Glycoproteins, Membrane Transport Proteins (genetics), Middle Aged, Midwestern United States, Minisatellite Repeats (genetics), Monoamine Oxidase (genetics), Nerve Tissue Proteins, Parkinson Disease (diagnosis), Parkinson Disease (genetics), Parkinson disease, Parkinson's disease, Polymorphism, Polymorphism, Genetic (genetics), Regression Analysis, Sex Factors, case‐control study, polymorphisms, susceptibility genes.
- MESH :
- chemical , genetics : Catechol O-Methyltransferase, Membrane Transport Proteins, Monoamine Oxidase.
- geographic : Midwestern United States, Nerve Tissue Proteins.
- diagnosis : Parkinson Disease.
- genetics : Minisatellite Repeats, Parkinson Disease, Polymorphism, Genetic.
- Adult, Age Factors, Aged, Aged, 80 and over, Case-Control Studies, Dopamine Plasma Membrane Transport Proteins, Female, Humans, Likelihood Functions, Male, Membrane Glycoproteins, Middle Aged, Regression Analysis, Sex Factors.
Abstract
We investigated the association of Parkinson's disease (PD) with dopamine transporter‐1 (DAT1), monoamine oxidase‐B (MAO‐B), and catechol‐O‐methyltransferase (COMT) gene polymorphisms. Overall, we observed no significant association of PD with the DAT1‐3′–variable numbers of tandem repeats, the MAO‐B‐(GT)n, and the COMT‐Val108Met gene polymorphisms in a sample of 319 unrelated PD cases and 196 control subjects. Analyses stratified by sex, age at examination, family history of PD, and ethnic origin also yielded negative findings, with three exceptions. We found statistically significant associations of PD with MAO‐B polymorphisms in older patients and with a COMT polymorphism in younger subjects and in women. These significant differences at the two‐tailed alpha level of 0.05 and restricted to subgroup analyses may have a biological basis or may be chance findings. © 2002 Movement Disorder Society
Url:
DOI: 10.1002/mds.10268
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001C20
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001C20
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002E40
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003906
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003906
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003B71
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000945
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000945
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000945
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006554
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002579
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000742
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002836
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006875
Links to Exploration step
ISTEX:17E4A865A2CDE279A9BE0325ECB6D6011FD31CD4Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease</title>
<author><name sortKey="Goudreau, John L" sort="Goudreau, John L" uniqKey="Goudreau J" first="John L." last="Goudreau">John L. Goudreau</name>
</author>
<author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name>
</author>
<author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name>
</author>
<author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name>
</author>
<author><name sortKey="Singleton, Andrew B" sort="Singleton, Andrew B" uniqKey="Singleton A" first="Andrew B." last="Singleton">Andrew B. Singleton</name>
</author>
<author><name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name>
</author>
<author><name sortKey="Hardy, John A" sort="Hardy, John A" uniqKey="Hardy J" first="John A." last="Hardy">John A. Hardy</name>
</author>
<author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:17E4A865A2CDE279A9BE0325ECB6D6011FD31CD4</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.10268</idno>
<idno type="url">https://api.istex.fr/document/17E4A865A2CDE279A9BE0325ECB6D6011FD31CD4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C20</idno>
<idno type="wicri:Area/Istex/Curation">001C20</idno>
<idno type="wicri:Area/Istex/Checkpoint">002E40</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Goudreau J:case:control:study</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12465073</idno>
<idno type="wicri:Area/PubMed/Corpus">003906</idno>
<idno type="wicri:Area/PubMed/Curation">003906</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003B71</idno>
<idno type="wicri:Area/Ncbi/Merge">000945</idno>
<idno type="wicri:Area/Ncbi/Curation">000945</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000945</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Goudreau J:case:control:study</idno>
<idno type="wicri:Area/Main/Merge">006554</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:03-0039043</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002579</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000742</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002836</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Goudreau J:case:control:study</idno>
<idno type="wicri:Area/Main/Merge">006875</idno>
<idno type="wicri:Area/Main/Curation">004548</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease</title>
<author><name sortKey="Goudreau, John L" sort="Goudreau, John L" uniqKey="Goudreau J" first="John L." last="Goudreau">John L. Goudreau</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Singleton, Andrew B" sort="Singleton, Andrew B" uniqKey="Singleton A" first="Andrew B." last="Singleton">Andrew B. Singleton</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hardy, John A" sort="Hardy, John A" uniqKey="Hardy J" first="John A." last="Hardy">John A. Hardy</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-11">2002-11</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1305">1305</biblScope>
<biblScope unit="page" to="1311">1311</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">17E4A865A2CDE279A9BE0325ECB6D6011FD31CD4</idno>
<idno type="DOI">10.1002/mds.10268</idno>
<idno type="ArticleID">MDS10268</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Amine oxidase (flavin-containing)</term>
<term>Biological transport</term>
<term>COMT</term>
<term>Case control study</term>
<term>Case-Control Studies</term>
<term>Catechol O-Methyltransferase (genetics)</term>
<term>Catechol O-methyltransferase</term>
<term>DAT1</term>
<term>Dopamine</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Exploration</term>
<term>Female</term>
<term>Genetics</term>
<term>Genotype</term>
<term>Human</term>
<term>Humans</term>
<term>Likelihood Functions</term>
<term>MAO‐B</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins (genetics)</term>
<term>Middle Aged</term>
<term>Midwestern United States</term>
<term>Minisatellite Repeats (genetics)</term>
<term>Monoamine Oxidase (genetics)</term>
<term>Nerve Tissue Proteins</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Polymorphism</term>
<term>Polymorphism, Genetic (genetics)</term>
<term>Regression Analysis</term>
<term>Sex Factors</term>
<term>case‐control study</term>
<term>polymorphisms</term>
<term>susceptibility genes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Catechol O-Methyltransferase</term>
<term>Membrane Transport Proteins</term>
<term>Monoamine Oxidase</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Midwestern United States</term>
<term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Minisatellite Repeats</term>
<term>Parkinson Disease</term>
<term>Polymorphism, Genetic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Case-Control Studies</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Female</term>
<term>Humans</term>
<term>Likelihood Functions</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Middle Aged</term>
<term>Regression Analysis</term>
<term>Sex Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Amine oxidase (flavin-containing)</term>
<term>Catechol O-methyltransferase</term>
<term>Dopamine</term>
<term>Etude cas témoin</term>
<term>Exploration</term>
<term>Génotype</term>
<term>Génétique</term>
<term>Homme</term>
<term>Parkinson maladie</term>
<term>Polymorphisme</term>
<term>Transport biologique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Génétique</term>
<term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We investigated the association of Parkinson's disease (PD) with dopamine transporter‐1 (DAT1), monoamine oxidase‐B (MAO‐B), and catechol‐O‐methyltransferase (COMT) gene polymorphisms. Overall, we observed no significant association of PD with the DAT1‐3′–variable numbers of tandem repeats, the MAO‐B‐(GT)n, and the COMT‐Val108Met gene polymorphisms in a sample of 319 unrelated PD cases and 196 control subjects. Analyses stratified by sex, age at examination, family history of PD, and ethnic origin also yielded negative findings, with three exceptions. We found statistically significant associations of PD with MAO‐B polymorphisms in older patients and with a COMT polymorphism in younger subjects and in women. These significant differences at the two‐tailed alpha level of 0.05 and restricted to subgroup analyses may have a biological basis or may be chance findings. © 2002 Movement Disorder Society</div>
</front>
</TEI>
<double idat="0885-3185:2002:Goudreau J:case:control:study"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease</title>
<author><name sortKey="Goudreau, John L" sort="Goudreau, John L" uniqKey="Goudreau J" first="John L." last="Goudreau">John L. Goudreau</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Singleton, Andrew B" sort="Singleton, Andrew B" uniqKey="Singleton A" first="Andrew B." last="Singleton">Andrew B. Singleton</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hardy, John A" sort="Hardy, John A" uniqKey="Hardy J" first="John A." last="Hardy">John A. Hardy</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0039043</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 03-0039043 INIST</idno>
<idno type="RBID">Pascal:03-0039043</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002579</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000742</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002836</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Goudreau J:case:control:study</idno>
<idno type="wicri:Area/Main/Merge">006875</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease</title>
<author><name sortKey="Goudreau, John L" sort="Goudreau, John L" uniqKey="Goudreau J" first="John L." last="Goudreau">John L. Goudreau</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Singleton, Andrew B" sort="Singleton, Andrew B" uniqKey="Singleton A" first="Andrew B." last="Singleton">Andrew B. Singleton</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hardy, John A" sort="Hardy, John A" uniqKey="Hardy J" first="John A." last="Hardy">John A. Hardy</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation</s1>
<s2>Jacksonville, Florida</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amine oxidase (flavin-containing)</term>
<term>Biological transport</term>
<term>Case control study</term>
<term>Catechol O-methyltransferase</term>
<term>Dopamine</term>
<term>Exploration</term>
<term>Genetics</term>
<term>Genotype</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Polymorphism</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Génotype</term>
<term>Polymorphisme</term>
<term>Génétique</term>
<term>Amine oxidase (flavin-containing)</term>
<term>Catechol O-methyltransferase</term>
<term>Transport biologique</term>
<term>Exploration</term>
<term>Homme</term>
<term>Dopamine</term>
<term>Etude cas témoin</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Génétique</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We investigated the association of Parkinson's disease (PD) with dopamine transporter-1 (DAT1), monoamine oxidase-B (MAO-B), and catechol-O-methyltransferase (COMT) gene polymorphisms. Overall, we observed no significant association of PD with the DAT1-3'-variable numbers of tandem repeats, the MAO-B-(GT)<sub>n</sub>
, and the COMT-Val108Met gene polymorphisms in a sample of 319 unrelated PD cases and 196 control subjects. Analyses stratified by sex, age at examination, family history of PD, and ethnic origin also yielded negative findings, with three exceptions. We found statistically significant associations of PD with MAO-B polymorphisms in older patients and with a COMT polymorphism in younger subjects and in women. These significant differences at the two-tailed alpha level of 0.05 and restricted to subgroup analyses may have a biological basis or may be chance findings.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease</title>
<author><name sortKey="Goudreau, John L" sort="Goudreau, John L" uniqKey="Goudreau J" first="John L." last="Goudreau">John L. Goudreau</name>
</author>
<author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name>
</author>
<author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name>
</author>
<author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name>
</author>
<author><name sortKey="Singleton, Andrew B" sort="Singleton, Andrew B" uniqKey="Singleton A" first="Andrew B." last="Singleton">Andrew B. Singleton</name>
</author>
<author><name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name>
</author>
<author><name sortKey="Hardy, John A" sort="Hardy, John A" uniqKey="Hardy J" first="John A." last="Hardy">John A. Hardy</name>
</author>
<author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:17E4A865A2CDE279A9BE0325ECB6D6011FD31CD4</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.10268</idno>
<idno type="url">https://api.istex.fr/document/17E4A865A2CDE279A9BE0325ECB6D6011FD31CD4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C20</idno>
<idno type="wicri:Area/Istex/Curation">001C20</idno>
<idno type="wicri:Area/Istex/Checkpoint">002E40</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Goudreau J:case:control:study</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12465073</idno>
<idno type="wicri:Area/PubMed/Corpus">003906</idno>
<idno type="wicri:Area/PubMed/Curation">003906</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003B71</idno>
<idno type="wicri:Area/Ncbi/Merge">000945</idno>
<idno type="wicri:Area/Ncbi/Curation">000945</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000945</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Goudreau J:case:control:study</idno>
<idno type="wicri:Area/Main/Merge">006554</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease</title>
<author><name sortKey="Goudreau, John L" sort="Goudreau, John L" uniqKey="Goudreau J" first="John L." last="Goudreau">John L. Goudreau</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lesnick, Timothy G" sort="Lesnick, Timothy G" uniqKey="Lesnick T" first="Timothy G." last="Lesnick">Timothy G. Lesnick</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Singleton, Andrew B" sort="Singleton, Andrew B" uniqKey="Singleton A" first="Andrew B." last="Singleton">Andrew B. Singleton</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bower, James H" sort="Bower, James H" uniqKey="Bower J" first="James H." last="Bower">James H. Bower</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hardy, John A" sort="Hardy, John A" uniqKey="Hardy J" first="John A." last="Hardy">John A. Hardy</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurogenetics Laboratory, Department of Neuroscience, Mayo Clinic and Mayo Foundation, Jacksonville, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rocca, Walter A" sort="Rocca, Walter A" uniqKey="Rocca W" first="Walter A." last="Rocca">Walter A. Rocca</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-11">2002-11</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1305">1305</biblScope>
<biblScope unit="page" to="1311">1311</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">17E4A865A2CDE279A9BE0325ECB6D6011FD31CD4</idno>
<idno type="DOI">10.1002/mds.10268</idno>
<idno type="ArticleID">MDS10268</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>COMT</term>
<term>Case-Control Studies</term>
<term>Catechol O-Methyltransferase (genetics)</term>
<term>DAT1</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Female</term>
<term>Humans</term>
<term>Likelihood Functions</term>
<term>MAO‐B</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins (genetics)</term>
<term>Middle Aged</term>
<term>Midwestern United States</term>
<term>Minisatellite Repeats (genetics)</term>
<term>Monoamine Oxidase (genetics)</term>
<term>Nerve Tissue Proteins</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson's disease</term>
<term>Polymorphism, Genetic (genetics)</term>
<term>Regression Analysis</term>
<term>Sex Factors</term>
<term>case‐control study</term>
<term>polymorphisms</term>
<term>susceptibility genes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Catechol O-Methyltransferase</term>
<term>Membrane Transport Proteins</term>
<term>Monoamine Oxidase</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Midwestern United States</term>
<term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Minisatellite Repeats</term>
<term>Parkinson Disease</term>
<term>Polymorphism, Genetic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Case-Control Studies</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Female</term>
<term>Humans</term>
<term>Likelihood Functions</term>
<term>Male</term>
<term>Membrane Glycoproteins</term>
<term>Middle Aged</term>
<term>Regression Analysis</term>
<term>Sex Factors</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We investigated the association of Parkinson's disease (PD) with dopamine transporter‐1 (DAT1), monoamine oxidase‐B (MAO‐B), and catechol‐O‐methyltransferase (COMT) gene polymorphisms. Overall, we observed no significant association of PD with the DAT1‐3′–variable numbers of tandem repeats, the MAO‐B‐(GT)n, and the COMT‐Val108Met gene polymorphisms in a sample of 319 unrelated PD cases and 196 control subjects. Analyses stratified by sex, age at examination, family history of PD, and ethnic origin also yielded negative findings, with three exceptions. We found statistically significant associations of PD with MAO‐B polymorphisms in older patients and with a COMT polymorphism in younger subjects and in women. These significant differences at the two‐tailed alpha level of 0.05 and restricted to subgroup analyses may have a biological basis or may be chance findings. © 2002 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004548 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004548 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:17E4A865A2CDE279A9BE0325ECB6D6011FD31CD4 |texte= Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |